TapewireFind a company

person · Reporting owner

Laponis Adam

Disclosed activity across 2 companies

Tapewire entity
19815
SEC CIK
0001827198

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Eargo, Inc.EAR · Entity 94112Chief Financial OfficerNovember 20, 2023November 22, 2023
Twist Bioscience CorpTWST · Entity 3619Chief Financial OfficerOctober 09, 2026October 13, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Eargo, Inc.

Report date November 20, 2023 · Filed November 22, 2023

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect258 Reported balance After 2023-11-20 transaction · row 1
1 source row

Row 1 · 2023-11-20 · Disposition to issuer · Disposed 33 · Balance 258

F1: This sale was effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2023.

Filing footnotes · ownership attribution and instrument terms

F1: This sale was effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2023.

Twist Bioscience Corp

Report date October 09, 2026 · Filed October 13, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect98,114 Reported balance After 2026-10-09 transaction · row 1
1 source row

Row 1 · 2026-10-09 · Sale · Disposed 2,462 · Balance 98,114

F1: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Filing footnotes · ownership attribution and instrument terms

F1: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
November 22, 2022 Filed Nov 25, 2022 13:05 UTC Eargo, Inc. EAR · Entity 94112 OtherSubscription Rights (right to buy) · Derivative 525 $0.00 Strike: $0.50 $0.00
Disclosure

SEC source: 0000899243-22-037000 · doc4.xml · derivative · entry 2

Laponis Adam · CIK 0001827198 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,995 shares

Expires not disclosed

F2 · derivative.exercise_price: Represents exercise price per whole share of Common Stock.

F3 · derivative.expiration_date: The Rights Offering expired on November 17, 2022, and final determination of the pro rata allocation for each exercising holder was determined on November 22, 2022.

Read SEC document
November 22, 2022 Filed Nov 25, 2022 13:05 UTC Eargo, Inc. EAR · Entity 94112 OtherCommon Stock 4,995 $0.50 $2,497.50
Disclosure

SEC source: 0000899243-22-037000 · doc4.xml · nonDerivative · entry 1

Laponis Adam · CIK 0001827198 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,222

F1 · shares: Represents shares of the Issuer's Common Stock acquired by the Reporting Person following the exercise of his basic subscription rights in connection with the Issuer's rights offering to holders of Common Stock, as described in the issuer's prospectus dated October 27, 2022 (the "Rights Offering"). Each holder of Common Stock of record as of October 24, 2022 received one right for each share of Common Stock, and each right entitled the holder of Common Stock to purchase 9.5151 shares of Common Stock at the subscription price of $0.50 per whole share.

Read SEC document
November 17, 2022 Filed Nov 21, 2022 17:52 UTC Eargo, Inc. EAR · Entity 94112 SaleCommon Stock 687 $0.52 $356.69
Disclosure

SEC source: 0000899243-22-036555 · doc4.xml · nonDerivative · entry 1

Laponis Adam · CIK 0001827198 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,227

F1 · shares: Reflects the number of shares of Common Stock that were sold to satisfy tax withholding requirements on vesting of restricted stock units pursuant to the Issuer's automatic sell to cover program, and does not represent a discretionary sale by the Reporting Person. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees.

F2 · price: The price reported in Column 4 is a weighted average price. These shares of Common Stock were sold in multiple transactions at prices ranging from $0.5114 to $0.5256, inclusive. Upon request, the Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission full information regarding the shares of Common Stock sold at each separate price within the range set forth in this footnote.

Read SEC document
August 15, 2022 Filed Aug 29, 2022 20:36 UTC Eargo, Inc. EAR · Entity 94112 Tax withholdingCommon Stock 357 $1.14 $406.98
Disclosure

SEC source: 0000899243-22-030017 · doc4.xml · nonDerivative · entry 4

Laponis Adam · CIK 0001827198 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,914

F2 · kind: Constitute Restricted Stock Units that were withheld to satisfy tax liabilities arising from the settlement of vested Restricted Stock Units.

Read SEC document
May 31, 2022 Filed Aug 29, 2022 20:36 UTC Eargo, Inc. EAR · Entity 94112 Tax withholdingCommon Stock 714 $1.55 $1,106.70
Disclosure

SEC source: 0000899243-22-030017 · doc4.xml · nonDerivative · entry 3

Laponis Adam · CIK 0001827198 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,271

F2 · kind: Constitute Restricted Stock Units that were withheld to satisfy tax liabilities arising from the settlement of vested Restricted Stock Units.

Read SEC document
March 09, 2022 Filed Aug 29, 2022 20:36 UTC Eargo, Inc. EAR · Entity 94112 Tax withholdingCommon Stock 423 $4.01 $1,696.23
Disclosure

SEC source: 0000899243-22-030017 · doc4.xml · nonDerivative · entry 2

Laponis Adam · CIK 0001827198 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,985

F2 · kind: Constitute Restricted Stock Units that were withheld to satisfy tax liabilities arising from the settlement of vested Restricted Stock Units.

Read SEC document
March 09, 2022 Filed Aug 29, 2022 20:36 UTC Eargo, Inc. EAR · Entity 94112 Disposition to issuerCommon Stock 608 $4.01 $2,438.08
Disclosure

SEC source: 0000899243-22-030017 · doc4.xml · nonDerivative · entry 1

Laponis Adam · CIK 0001827198 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,408

F1 · kind: Constitute vested Restricted Stock Units that were settled in cash.

Read SEC document
August 17, 2021 Filed Aug 19, 2021 17:46 UTC Eargo, Inc. EAR · Entity 94112 Tax withholdingCommon Stock 359 $24.54 $8,808.89
Disclosure

SEC source: 0000899243-21-033683 · doc4.xml · nonDerivative · entry 1

Laponis Adam · CIK 0001827198 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,016

F1 · kind: These shares were withheld so that the Reporting Person could satisfy tax liability arising from the release of vested Restricted Stock Units.

F2 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $24.4601 to $24.6650 per share. Information on the actual number of shares sold at each sale price can be obtained from the Issuer upon request.

F3 · balance_after: Reflects the adjusted total which includes an aggregate of 1,807 shares of the Issuer's common stock purchased under the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3.

Read SEC document
June 29, 2021 Filed Jul 1, 2021 17:32 UTC Eargo, Inc. EAR · Entity 94112 Exercise / conversionStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $2.55 $0.00
Disclosure

SEC source: 0000899243-21-026983 · doc4.xml · derivative · entry 3

Laponis Adam · CIK 0001827198 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 133,692

Underlying: Common Stock · 10,000 shares

Expires 2029-06-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock option is partially vested and shall vest and become exercisable with respect to 25% of the shares subject to the stock option on the first anniversary of June 3, 2019 (the "Vesting Start Date") and one forty-eighth (1/48th) of the shares of subject to the option shall vest and become exercisable on each monthly anniversary thereafter until all of the shares subject to the stock option have vested and became exercisable on the fourth anniversary of the Vesting Start Date, so long as the Reporting Person remains an employee, consultant, director or officer of the Issuer through each such date.

F3 · derivative.exercise_date: The Vesting Start Date, vesting schedule and the expiration date were previously misreported in a Form 3 filed on October 15, 2020.

F3 · derivative.expiration_date: The Vesting Start Date, vesting schedule and the expiration date were previously misreported in a Form 3 filed on October 15, 2020.

Read SEC document
June 29, 2021 Filed Jul 1, 2021 17:32 UTC Eargo, Inc. EAR · Entity 94112 SaleCommon Stock 10,000 $38.43 $384,300.00
Disclosure

SEC source: 0000899243-21-026983 · doc4.xml · nonDerivative · entry 2

Laponis Adam · CIK 0001827198 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,568

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
June 29, 2021 Filed Jul 1, 2021 17:32 UTC Eargo, Inc. EAR · Entity 94112 Exercise / conversionCommon Stock 10,000 $2.55 $25,500.00
Disclosure

SEC source: 0000899243-21-026983 · doc4.xml · nonDerivative · entry 1

Laponis Adam · CIK 0001827198 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,568

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 17, 2021 Filed May 19, 2021 17:10 UTC Eargo, Inc. EAR · Entity 94112 Tax withholdingCommon Stock 362 $33.98 $12,302.53
Disclosure

SEC source: 0000899243-21-019950 · doc4.xml · nonDerivative · entry 1

Laponis Adam · CIK 0001827198 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,568

F1 · kind: These shares were withheld so that the Reporting Person could satisfy tax liability arising from the release of vested Restricted Stock Units.

F2 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $33.86 to $34.07 per share. Information on the actual number of shares sold at each sale price can be obtained from the Issuer upon request.

Read SEC document
January 29, 2021 Filed Feb 4, 2021 21:47 UTC Eargo, Inc. EAR · Entity 94112 GrantStock Option (Right to Buy) · Derivative 16,500 $0.00 Strike: $52.58 $0.00
Disclosure

SEC source: 0000899243-21-004982 · doc4.xml · derivative · entry 2

Laponis Adam · CIK 0001827198 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,500

Underlying: Common Stock · 16,500 shares

Expires 2031-01-28

F2 · derivative.exercise_date: The stock option shall vest and become exercisable with respect to 16 quarterly installments commencing on February 15, 2021, so long as the Reporting Person remains an employee, consultant, director or officer of the Issuer through each such date.

Read SEC document
January 29, 2021 Filed Feb 4, 2021 21:47 UTC Eargo, Inc. EAR · Entity 94112 GrantCommon Stock 16,500 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-004982 · doc4.xml · nonDerivative · entry 1

Laponis Adam · CIK 0001827198 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,930

F1 · shares: Represents Restricted Stock Units ("RSUs") which vest in 16 quarterly installments commencing on February 15, 2021, so long as the Reporting Person remains an employee, consultant, director or officer of the Issuer through each such date. Each RSU represents a contingent right to receive one (1) share of common stock of the Issuer.

Read SEC document
October 20, 2020 Filed Oct 22, 2020 18:47 UTC Eargo, Inc. EAR · Entity 94112 ConversionSeries E Preferred Stock · Derivative 11,097 $0.00 $0.00
Disclosure

SEC source: 0000899243-20-029067 · doc4.xml · derivative · entry 2

Laponis Adam · CIK 0001827198 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,097 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Series E Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.

F1 · derivative.exercise_date: The Series E Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.

F1 · derivative.expiration_date: The Series E Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.

Read SEC document
October 20, 2020 Filed Oct 22, 2020 18:47 UTC Eargo, Inc. EAR · Entity 94112 ConversionCommon Stock 11,097 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-20-029067 · doc4.xml · nonDerivative · entry 1

Laponis Adam · CIK 0001827198 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,430

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The Series E Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.